ck life sciences intl hldgs
(775:Stock Exchange of Hong Kong Limited)
ck life sciences intl hldgs (775) Snapshot
|
Open
--
|
Previous Close
--
|
|
|
Day High
--
|
Day Low
--
|
|
|
52 Week High
-- - --
|
52 Week Low
-- - --
|
|
|
Market Cap
--
|
Average Volume 10 Days
0.0
|
|
|
EPS TTM
--
|
Shares Outstanding
0.0
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
ck life sciences intl hldgs (775) Related Businessweek News
No Related Businessweek News Foundck life sciences intl hldgs (775) Details
CK Life Sciences Int’l., (Holdings) Inc., an investment holding company, engages in the research, development, manufacture, commercialization, marketing, and sale of health and agriculture-related products in the Asia Pacific and North America. It engages in the manufacture and marketing of plant protection products and soluble fertilizers; manufacture, blending, distribution, and sale of fertilizers, pesticides, and related agricultural products; manufacture and distribution of horticultural products; and contract manufacturing of complementary healthcare medicines and production of non-sterile prescription and over-the-counter medicines. The company is also involved in licensing of registration activities and the importation of finished agricultural goods; holding land and building; financing, water treatment, and trustee activities; investment in financial instruments, and vineyards and wineries; trade of biotechnology products and nutritional supplements; and manufacture, wholesale, retail, and distribution of nutraceutical products. In addition, it engages in the distribution of turf management machinery, hardware, equipment, and accessories; and chemicals and professional pest products, as well as provides related services. The company’s products include emulsifiable concentrates, suspension concentrates, aqueous solutions, coated granules, powders, and amination based reactions for crop protection; crop-specific fertiliser solutions for fruits, vegetables, broadacre and other specialty crops; and pharmaceutical products, such as Tetrodotoxin and POL-103A that are in advanced stages of clinical development, as well as CKBP002 and CKBP004 that are in pre-clinical studies for the treatment of cancer. CK Life Sciences Int’l., (Holdings) Inc. is headquartered in Tai Po, Hong Kong.
Last Reported Date: 04/2/13
ck life sciences intl hldgs (775) Top Compensated Officers
ck life sciences intl hldgs (775) Key Developments
CK Life Sciences International Holdings Inc. reported consolidated audited cash flow results for the year ended December 31, 2012. For the year, the company reported net cash from operating activities of HKD 435,403,000 against HKD 121,512,000 a year ago. Purchases of property, plant and equipment was HKD 89,181,000 against HKD 111,094,000 a year ago.
CK Life Sciences International Holdings Inc., Annual General Meeting, May 20, 2013., at 10:00 China Standard Time. Location: The Ballroom, 1st Floor, Harbour Grand Kowloon. Agenda: To approve final dividend for the year 2012; to receive the audited financial statements, the report of the directors and the independent auditor's report for the year ended December 31, 2012; to declare a final dividend; to elect directors; to appoint auditor and authorise the directors to fix their remuneration; and to consider other business issues.
CK Life Sciences International Holdings Inc. reported consolidated earnings results for the year ended December 31, 2012. For the year, the company's turnover was HKD 4.5 billion compared with HKD 3.5 billion a year ago. Profit before taxation was HKD 0.3 billion compared with HKD 0.16 billion a year ago. Profit for the year was HKD 0.198 billion compared with HKD 0.12 billion a year ago. Profit attributable to shareholders of the company was HKD 0.18 billion or 1.83 cents per diluted share compared with HKD 0.13 billion or 1.31 cents per diluted share a year ago. The Board of Directors has recommended a final dividend of HKD 0.006 per share for the year ended 31 December 2012, a 20% increase over the previous year. The proposed dividend will be paid on 5 June 2013 following approval at the 2013 annual general meeting to those shareholders whose names appear on the register of members of the company at close of business on 24 May 2013.
| Recently Viewed | |||
| 775:HK | $0.71 HKD | -0.02 | |
| Company | Last | Change |
| AVIC International Holding HK Ltd | $0.39 HKD | 0.00 |
| Hutchison Harbour Ring Ltd | $0.64 HKD | 0.00 |
| View Industry Companies | ||
Industry Analysis
775
Industry Average
| Valuation | 775 | Industry Range |
| Price/Earnings | 39.7x |
|
| Price/Sales | 1.5x |
|
| Price/Book | 1.3x |
|
| Price/Cash Flow | 28.5x |
|
| TEV/Sales | 0.8x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact CK LIFE SCIENCES INTL HLDGS, please visit www.ck-lifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








